Ketamine for depression with suicidal thoughts in teens
Part of Mental health clinical trials.
This study tests a medicine called ketamine (given as a shot under the skin) to see if it helps reduce depression and suicidal thoughts in teenagers. It is for teens aged 12 to 19 who are already getting treatment for depression but still have serious suicidal thoughts or have attempted suicide.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 19 years old.
- You must have a diagnosis of major depression (without bipolar or other serious mental health conditions).
- You must be getting usual care for depression, like therapy or medication.
- You must be having serious suicidal thoughts, have made a plan, or have attempted suicide within the last month.
- You cannot have serious heart, brain, or other medical conditions like stroke or brain injury.
- You cannot have used ketamine or similar substances in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This trial tests if esketamine (a nasal spray) can quickly reduce symptoms of major depression and suicidal thoughts in teenagers who need urgent hospital care.
This Phase 3 study tests ketamine to reduce ongoing suicidal thoughts and help prevent another suicide attempt in youth after a recent attempt. It will compare ketamine treatment against standard care to see if it helps improve safety and reduce suicide risk.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This Phase 4 study tests whether ongoing treatment with ketamine or esketamine can reduce suicidal thoughts in people with major depression who are at high risk. Because the study focuses on long-term maintenance, you’d receive treatment over time while being closely monitored for safety and mental health changes.
Hear when a new Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.